Sep 2026
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms.
Importance Vasomotor symptoms in perimenopause are associated with increased future cardiovascular (CVD) risk. Most clinical trials on menopausal hormone therapy (MHT) and CVD risk have focused on postmenopausal women, with limited study of the perimenopausal period when hormonal fluctuations and symptoms are greatest....
Zi-Yuan Wang, S. Swanson, M. Brooks et al.
· JAMA Internal Medicine · 1 citation